HSBC Mortgage Corp. moved Friday to sanction the plaintiffs' lawyer in an overtime, meal and rest period compensation and unlawful deductions suit, alleging that the lawyer directed a class representative to destroy evidence.
In the latest salvo over generic versions of the cancer drug Thalomid, generic-drug maker Barr Laboratories Inc. said on Thursday that Celgene Corp.'s patent claims are unenforceable because the inventor withheld material information as the application wended its way through the U.S. Patent and Trademark Office.
Bankrupt department store chain Boscov's Inc. has received final approval of a $250 million debtor-in-possession loan that the company says will allow it to continue its operations with an uninterrupted "merchandise flow" going into the holiday sales season.
A federal judge has rejected drugmaker GlaxoSmithKline PLC's contention that federal law preempts a failure-to-warn product liability suit over Paxil, in a case involving a 16-year-old boy who killed himself while taking the antidepressant.
Defunct trucking company APA Transport Corp. will have to come up with a new defense for its failure to provide hundreds of employees with a 60-day notice of termination, now that an appeals court has reversed a lower court's decision to throw out the case by allowing the company to hide behind the “faltering company” exception to the Worker Adjustment and Retraining Notification Act.
Citing client conflicts and an economic downturn, WolfBlock LLP and Akerman Senterfitt have ended talks of a potential merger.
The U.S. Environmental Protection Agency has named six new Superfund sites to its National Priorities List and proposed adding an additional 10 sites, elevating them to high-priority areas in need of investigations into the potential health and environmental risks they pose.
A federal appeals court on Thursday upheld a district judge's decision to dismiss Apotex Inc.'s counterclaims of noninfringement in connection with a patent fight over Johnson & Johnson subsidiary Janssen's anti-psychotic drug Risperdal.
A federal appeals court has dealt Howmedica Osteonics Corp. a win in a long-running patent dispute between rival orthopedic implant makers over knee implants, vacating a stipulated judgment of noninfringement because of flaws in the lower court's claim construction.
Healthfirst, the largest Medicaid managed-care provider in New York state, has agreed to pay $35 million to settle an investigation into its prior marketing practices.
Pfizer Inc. has filed a new suit against Impax Laboratories Inc. over Impax's attempts to move into the lucrative market for Detrol LA, after Impax changed an abbreviated new drug application to cover a different dosage strength.
Teva Pharmaceuticals Industries Ltd. has filed a lawsuit accusing rival generic-drug maker Glenmark Pharmaceuticals Ltd. of infringing patents for the preparation of a generic version of Coreg, GlaxoSmithKline PLC's congestive heart failure treatment.
A lawsuit by the state of Ohio accusing lead paint manufacturers and distributors of creating a public nuisance in the state has no business in federal court, a magistrate judge has ruled, recommending that the matter be remanded to state court where it was originally filed.
Two Philadelphia brothers who operated a funeral home pled guilty Tuesday to several charges in connection with a multimillion-dollar human tissue harvesting ring, their lawyers have confirmed.
Less than four months after seeking Chapter 11 protection, home products retailer Linens 'N Things has filed a joint plan of reorganization that calls for closing nearly 200 stores and grants its creditors ownership of the company.
A judge has allowed counterclaims of monopolization, attempted monopolization and illegal conspiracy against leading phone maintenance company Avaya Inc. but dismissed some other counterclaims by a competing maintenance firm.
A judge on Thursday stayed two noninfringement lawsuits brought by generic-drug makers against AstraZeneca Corp. pending the outcome of AstraZeneca's earlier Nexium-related infringement cases.
Sanofi-Aventis has targeted Canada's Apotex Corp. in its latest effort to keep a generic version of colon cancer drug Eloxatin off the market in the United States.
A federal judge on Wednesday upheld key allegations in a putative class action after an employee of semiconductor-maker Conexant Systems Inc. accused it of mismanaging its 401(k) plan by overloading it with company stock, potentially costing employee-investors millions.
A federal judge handed Everett Laboratories Inc. a victory Tuesday in its patent infringement case by ordering Breckenridge Pharmaceutical Inc. to stop selling and marketing multivitamin Multifol Plus in the United States.